CoreFirst Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,400
| Closed | -$222K | – | 343 |
|
|
2024
Q2 | $222K | Hold |
2,400
| – | – | 0.15% | 116 |
|
|
2024
Q1 | $229K | Hold |
2,400
| – | – | 0.14% | 114 |
|
|
2023
Q4 | $183K | Hold |
2,400
| – | – | 0.12% | 127 |
|
|
2023
Q3 | $166K | Sell |
2,400
-540
| -18% | -$37.4K | 0.12% | 135 |
|
|
2023
Q2 | $277K | Sell |
2,940
-540
| -16% | -$50.9K | 0.2% | 104 |
|
|
2023
Q1 | $288K | Hold |
3,480
| – | – | 0.21% | 104 |
|
|
2022
Q4 | $260K | Buy |
3,480
+1,080
| +45% | +$80.6K | 0.2% | 112 |
|
|
2022
Q3 | $198K | Hold |
2,400
| – | – | 0.17% | 123 |
|
|
2022
Q2 | $228K | Hold |
2,400
| – | – | 0.18% | 118 |
|
|
2022
Q1 | $283K | Hold |
2,400
| – | – | 0.19% | 110 |
|
|
2021
Q4 | $311K | Hold |
2,400
| – | – | 0.2% | 106 |
|
|
2021
Q3 | $272K | Hold |
2,400
| – | – | 0.19% | 115 |
|
|
2021
Q2 | $249K | Hold |
2,400
| – | – | 0.17% | 121 |
|
|
2021
Q1 | $201K | Hold |
2,400
| – | – | 0.14% | 136 |
|
|
2020
Q4 | $219K | Buy |
+2,400
| New | +$219K | 0.16% | 118 |
|